BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasr M, Teiama M, Ismail A, Ebada A, Saber S. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis. Drug Deliv and Transl Res 2020;10:1841-52. [DOI: 10.1007/s13346-020-00830-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Vitoria Pupo Silvestrini A, Wender Debiasi B, Garcia Praça F, Vitoria Lopes Badra Bentley M. Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies. International Journal of Pharmaceutics 2022;628:122299. [DOI: 10.1016/j.ijpharm.2022.122299] [Reference Citation Analysis]
2 Abdellatif MM, Josef M, El-nabarawi MA, Teaima M. Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies. Pharmaceutics 2022;14:2215. [DOI: 10.3390/pharmaceutics14102215] [Reference Citation Analysis]
3 Zohny MH, Alrouji M, Alhajlah S, AlOmeir O, Ewees MGE, Ghaffar DMA, El Adle Khalaf N, Mohammed OA, Abdeldaiem MSI, El-Bahouty WB, Elrabat A, Zakaria S, Abdel-Nasser ZM, Haleem AA, El-Gharbawy DM, Abdelhady R, Kaddah MMY, Shata A, Saber S. Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis. Biomed Pharmacother 2022;154:113651. [PMID: 36081290 DOI: 10.1016/j.biopha.2022.113651] [Reference Citation Analysis]
4 Das B, Nayak AK, Mallick S. Lipid-based nanocarriers for ocular drug delivery: An updated review. Journal of Drug Delivery Science and Technology 2022;76:103780. [DOI: 10.1016/j.jddst.2022.103780] [Reference Citation Analysis]
5 Youssef ME, Abdel-reheim MA, Morsy MA, El-daly M, Atwa GMK, Yahya G, Cavalu S, Saber S, Ahmed Gaafar AG. Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats. IJMS 2022;23:10297. [DOI: 10.3390/ijms231810297] [Reference Citation Analysis]
6 El-kashef DH, Youssef ME, Nasr M, Alrouji M, Alhajlah S, Alomeir O, El Adle Khalaf N, Ghaffar DMA, Jamil L, Abdel-nasser ZM, Ibrahim S, Abdeldaiem MSI, Donia SS, Mohammed OA, Morsy NE, Shata A, Saber S. Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis. Biomedicine & Pharmacotherapy 2022;153:113487. [DOI: 10.1016/j.biopha.2022.113487] [Reference Citation Analysis]
7 Khalil R, Yahya G, Abdo WS, El-tanbouly GS, Johar D, Abdel-halim MS, Eissa H, Magheru C, Saber S, Cavalu S. Emerging Approach for the Application of Hibiscus sabdariffa Extract Ointment in the Superficial Burn Care. Sci Pharm 2022;90:41. [DOI: 10.3390/scipharm90030041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Polat HK, Kurt N, Aytekin E, Bozdağ Pehlivan S, Çalış S. Novel Drug Delivery Systems to Improve the Treatment of Keratitis. J Ocul Pharmacol Ther 2022. [PMID: 35763406 DOI: 10.1089/jop.2021.0127] [Reference Citation Analysis]
9 Nasr M, Saber S, Bazeed AY, Ramadan HA, Ebada A, Ciorba AL, Cavalu S, Elagamy HI. Advantages of Cubosomal Formulation for Gatifloxacin Delivery in the Treatment of Bacterial Keratitis: In Vitro and In Vivo Approach Using Clinical Isolate of Methicillin-Resistant Staphylococcus aureus. Materials 2022;15:3374. [DOI: 10.3390/ma15093374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Marson D, Aulic S, Laurini E, Pricl S. Cubosomes: a promising vesicular system for drug delivery. Systems of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91864-0.00021-8] [Reference Citation Analysis]
11 Mishra N, Singh N, Parashar P. In vivo evaluation and imaging of nanomaterials for theranostic applications. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases 2022. [DOI: 10.1016/b978-0-323-91201-3.00012-8] [Reference Citation Analysis]
12 Alhabbal A, Saber S, Aboukhamis I. The hidden danger in Syria: Silent Celiac Disease. RJPT 2021. [DOI: 10.52711/0974-360x.2021.01130] [Reference Citation Analysis]
13 Hosny KM, Rizg WY, Alkhalidi HM, Abualsunun WA, Bakhaidar RB, Almehmady AM, Alghaith AF, Alshehri S, El Sisi AM. Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment. Drug Deliv 2021;28:1836-48. [PMID: 34515597 DOI: 10.1080/10717544.2021.1965675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
14 Waheed A, Aqil M. Lyotropic liquid crystalline nanoparticles: Scaffolds for delivery of myriad therapeutics and diagnostics. Journal of Molecular Liquids 2021;338:116919. [DOI: 10.1016/j.molliq.2021.116919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nagaraj S, Manivannan S, Narayan S. Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review. J Basic Microbiol 2021. [PMID: 34351655 DOI: 10.1002/jobm.202100204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Abouelatta SM, Sheta AI, Ibrahim RR. Optimized molecular imprints in gamma-irradiated collagen shields of an antifungal drug: In vitro characterization, in-vivo bioavailability enhancement. Eur J Pharm Biopharm 2021;166:135-43. [PMID: 34166761 DOI: 10.1016/j.ejpb.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yahya G, Ebada A, Khalaf EM, Mansour B, Nouh NA, Mosbah RA, Saber S, Moustafa M, Negm S, El-Sokkary MMA, El-Baz AM. Soil-Associated Bacillus Species: A Reservoir of Bioactive Compounds with Potential Therapeutic Activity against Human Pathogens. Microorganisms 2021;9:1131. [PMID: 34073963 DOI: 10.3390/microorganisms9061131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Navarro-Partida J, Castro-Castaneda CR, Santa Cruz-Pavlovich FJ, Aceves-Franco LA, Guy TO, Santos A. Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases. Pharmaceutics 2021;13:678. [PMID: 34065059 DOI: 10.3390/pharmaceutics13050678] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]